Cathie Wood, the renowned investor and founder of ARK Invest, recently made some notable trades. Wood’s ARK Invest bought shares of Tempus AI, a company focused on data-driven precision medicine. At the same time, ARK Invest sold off its holdings in Teladoc, a telemedicine company. Wood’s decision to invest in Tempus AI reflects her belief in the potential of data-driven healthcare solutions. Teladoc, on the other hand, saw a decrease in ARK Invest’s confidence, leading to the decision to sell off its stock. Wood’s strategic moves in the market continue to draw attention from investors and analysts alike.
Subscribe
Login
0 Comments